[Extracorporeal shock wave lithotripsy in patients with coagulopathies: report of three cases].
We describe our experience with extracorporeal shock wave lithotripsy (ESWL) in three patients with coagulation disorders (one case of hemophilia A, and two cases of thromboasthenia). We successfully performed ESWL using factor VIII or transfusion of platelets without any severe hemorrhagic complications, such as perirenal and subcapsural hematomas. We consider that adequate supplement of coagulation factor or platelets may lower the risk of hemorrhagic complications in coagulopathic patients who undergo ESWL.
Onishi
T
T
Department of Urology, Mie University School of Medicine.
Shibahara
T
T
Kise
H
H
Okuno
T
T
Hayashi
N
N
Arima
K
K
Yanagawa
M
M
Kawamura
J
J
D000328:Adult; D001778:Blood Coagulation Disorders / Q000150:complications*; D002648:Child; D005169:Factor VIII / Q000008:administration & dosage; D005260:Female; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008096:Lithotripsy; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion; D014545:Urinary Calculi / Q000150:complications / Q000628:therapy*
D005169:Factor VIII